XTL Biopharmaceuticals Ltd. financial statements
XTL Biopharmaceuticals Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 451K | 20-F |
| Net income | −USD 1.03M | 20-F |
| Cash and equivalents | USD 371K | 20-F |
| Total debt | USD 138K | 20-F |
XTL Biopharmaceuticals Ltd. financials on 6ix · XTL Biopharmaceuticals Ltd. on 6ix